US 2021 presidential transition: The first 100 days
Supported by our latest insights, EY is here to help you understand and prioritize how the new administration will shape the US legislative and regulatory environment on a range of issues impacting your business now, next and beyond.
How life sciences executives can navigate the post-US election uncertainty
2021 is expected to begin with a transition from the elections and vaccine distribution, with hopes of a smoother second half.
The coronavirus crisis will continue to demand the attention of Congress, but congressional leaders also could face new challenges. Growing federal debt and limited state budgets will make it difficult for either party with control in Congress to advance big-ticket policies — such as enabling permanent telehealth reimbursement or major health care reforms — without also identifying budgetary offsets.